Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Journal of Oncology Nursing|March 19, 2017
CAR T-Cell Therapy: Pediatric Patients With Relapsed and Refractory Acute Lymphoblastic Leukemia
Colleen Callahan, Diane Baniewicz, Beth ElyClinical Journal of Oncology Nursing|March 19, 2019
Pediatric Survivorship: Considerations Following CAR T-Cell TherapyColleen Callahan, Amy Barry, Stephanie Fooks-Parker, et al.Clinical Journal of Oncology Nursing|March 19, 2017
Cancer Immunotherapy: An Evidence-Based Overview and Implications for PracticeVirginia Bayer, Beau Amaya, Diane Baniewicz, et al.Pediatric Blood & Cancer|April 16, 2011
Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastomaKelsey Johnson, Barbara McGlynn, Jennifer Saggio, et al.Clinical Journal of Oncology Nursing|March 19, 2017
Immunotherapy Administration: Oncology Nursing Society Recommendations
Kathleen Wiley, Kristine B LeFebvre, Lisa Wall, et al.The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.Pageof 2